机构:[1]Department of Ophthalmology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhi Zao Ju Road, Shanghai 200011, People’s Republic of China[2]Beijing Tongren Eye Centre, Beijing Ophthalmology & Visual Sciences Key Lab, Tongren Hospital, Capital Medical University, Beijing Economic-Technological Development Area, Beijing 100176, People’s Republic of China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Department of Endocrinology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhi Zao Ju Road, Shanghai 200011, People’s Republic of China[4]Department of Ophthalmology, People’s Hospital, Wu Han University, No. 238 Jie Fang Road, Wu Han 430060, People’s Republic of China
Retinoblastoma is an aggressive eye cancer that develops during infancy and is divided into two clinical types, sporadic and heritable. RB1 has been identified as the only pathological gene responsible for heritable retinoblastoma. Here, we identified 11 RB1 germline mutations in the Han pedigrees of 17 bilateral retinoblastoma patients from China. Four mutations were nonsense mutations, five were splice site mutations, and two resulted in a frame shift due to an insertion or a deletion. Three of the mutations had not been previously reported, and the p.Q344L mutation occurred in two generations of retinoblastoma patients. We investigated phenotypic-genotypic relationships for the novel mutations and showed that these mutations affected the expression, location, and function of the retinoblastoma protein. Abnormal protein localization was observed after transfection of the mutant genes. In addition, changes in the cell cycle distribution and apoptosis rates were observed when the Saos-2 cell line was transfected with plasmids encoding the mutant RB1 genes. Our findings expand the spectrum of known RB1 mutations and will benefit the investigation of RB1 mutation hotspots. Genetic counseling can be offered to families with heritable RB1 mutations.
基金:
Scientific Research Program of National Health and Family Planning Commission of China [2014040]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172323, 81372909]; Science and Technology Commission of ShanghaiScience & Technology Commission of Shanghai Municipality (STCSM) [12ZR1417300, 13ZR1423600]
第一作者机构:[1]Department of Ophthalmology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhi Zao Ju Road, Shanghai 200011, People’s Republic of China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhang Leilei,Jia Renbing,Zhao Junyang,et al.Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma[J].TUMOR BIOLOGY.2015,36(4):2409-2420.doi:10.1007/s13277-014-2851-7.
APA:
Zhang, Leilei,Jia, Renbing,Zhao, Junyang,Fan, Jiayan,Zhou, YiXiong...&Fan, Xianqun.(2015).Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma.TUMOR BIOLOGY,36,(4)
MLA:
Zhang, Leilei,et al."Novel mutations in the RB1 gene from Chinese families with a history of retinoblastoma".TUMOR BIOLOGY 36..4(2015):2409-2420